Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig
doi: 10.1016/S0735-1097(01)01769-7 100 ZengCDuanFHuJLuoBHuangBLouXet al
Mohd Ariffin NH, Hasham R
Discuss with your health care provider what approach is right for you
US$ 20.01
:format(webp))
US$ 25.93
US$ 29.91
US$ 27.52
